Congratulations to the following individuals for obtaining extramural funding from federal, state, and/or independent sources between November 1, 2021 - January 31, 2022!
NOTE: If any information has been inadvertently omitted, please contact the editor (dflock@lsuhsc.edu) and a correction will be printed in the next issue of The Pulse.
National Institutes of Health (R13)
Charles Wood, PhD (Interdisciplinary Oncology)
“Organizing an International KSHV meeting in Dar es Salaam, Tanzania for 2023”
Pharmaceutical, Professional Society and Private Grants
Merritt Brown III, MD (Department of Neurosurgery)
Mitsubishi Tanabe Pharma Development
“A Phase 2a, Randomized, Double-blinded, Placebo-controlled Study to Assess the Efficacy
and Safety of MT-3921 in subjects with Acute Traumatic Cervical Spinal Cord Injury”
Michael Hagensee, MD, PhD (Departments of Medicine and Microbiology, Immunology and
Parasitology)
Merck
“Phase 3 Multicenter, Open-label Study to Evaluate the Safety and Immunogenicity of
2-dose Regimens of 9VHPV and mRNA-1273 SARS-Cov-2 Vaccines Where the First Dose of
Each Vaccine are Given Concomitantly in Adolescent”
Augusto Ochoa, MD (Stanley S. Scott Cancer Center)
Leidos Biomedical Research, Inc.
“Leidos/Theradex Systems NCI Moonshot Biobank Study Protocol 10323”
Stephanie Taylor, MD (Department of Microbiology, Immunology and Parasitology)
Becton Dickinson Corp
“Extragenital CT/GC Testing with the CTGCTV2 Assay on the BD COR System Protocol VV-TMF-220475”
Foundation Grants
Charles Nichols, PhD, (Department of Pharmacology and Experimental Therapeutics)
RiverStyx Foundation
“Examining the Potential of Psychedelics to Treat Arthritis”
Ryan Pasternak, MD (Department of Pediatrics)
Packard Foundation
“Expanding Adolescent Reproductive and Sexual Health Care and Advance the Southern
Center's Four Pillars of Clinical Care: Education, Advocacy/Community Engagement,
and Quality Improvement/Research”
(with the Southern Center for Adolescent and Young Adult Health Equity)